All News #Library
Others
K36 Therapeutics Announces Appointment of Benjamin Winograd as CMO
15 Nov 2023 //
PR NEWSWIRE
K36 Therapeutics raises $70M in Series B to fund multiple myeloma research
28 Jun 2023 //
ENDPTS

Market Place
Sourcing Support